Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)
Clinical trial NCT03053063 · TERMINATED
Trial details
- NCT number
- NCT03053063
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-30
- Primary completion
- 2019-05-06
- Enrollment
- 883
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.